|Year : 2019 | Volume
| Issue : 2 | Page : 103
Application of new technologies in the health sciences: A guideline
Carlos Fernando de Almeida Barros Mourão1, Natália Belmock Mascarenhas Freitas Mourão2
1 Department of Oral Surgery, Dentistry School, Fluminense Federal University, Niterói, Brazil
2 Department of Public Health, Sergio Arouca Public Health School, Fiocruz, Rio de Janeiro, Brazil
|Date of Web Publication||8-May-2019|
Carlos Fernando de Almeida Barros Mourão
Rua Mario Santos Braga, 28/4° Andar - Centro, Niterói, Rio de Janeiro 24020-140
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Barros Mourão CF, Freitas Mourão NB. Application of new technologies in the health sciences: A guideline. Adv Hum Biol 2019;9:103
The evaluation of health technologies is a continuous process that aims at systematic study of both the long- and short-term consequences of their use. New technologies can include the use of a particular medicine, equipment for use in all stages of development, from laboratory to bedside, or a group of innovations or different methods. This is a multidisciplinary evaluation, aiming to provide guidelines in the use of new technology. These guidelines and procedures aim to guarantee the safety of both the specialist who will apply the product/method and the patient.
In our opinion, Translational Research is the best process to evaluate new technologies as it includes different stages: in vitro studies, in vivo studies and clinical trials.
These stages are essential for good technological development in medical research, providing a complete evaluation and of the effects of the new technology.
When considering the use of new technologies in health sciences, three questions should be asked:
- What are the patient's needs?
- Is there access to the necessary infrastructure to adequately to conduct laboratory and clinical tests exist?
- Is it economically viable?
The most relevant issue is the patient's needs. Improving the patient's quality of life should always be the ultimate objective of any medical research.
Laboratory and clinical assessments are essential to receive support from different areas such as government agencies, private companies and doctors.
Economic feasibility, including the cost of production and the cost-effectiveness ratio, is obviously important. Are government support/subsidies necessary, and if so, is it available? What is the private sector investment potential? Are there similar products on the market? These questions should be kept in mind during research on new technologies.
As a personal example, our research on bone substitutes. The patient's needs were biocompatible and osteoconductive material, reabsorbility and a more efficient drug delivery system.
We have access to excellent university laboratories and researchers. This allowed to improve the materials using Translational Research.
In our case, both the government and private companies contributed both financially and in kind.
Thereby, research of new medical technologies should be conduct by those three questions that we appointed in this text because they are relevant to evaluate the quality and the application of the new material that we will use in our patients.